Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-12-24

Clinical Trial Update: Antioxidant Treatment of Type 2 Diabetes [EARLY_Phase 1]

View source ↗

Summary

This document reports that an early Phase 1 trial evaluating an antioxidant treatment for Type 2 diabetes mellitus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Type 2 Diabetes | EARLY_Phase 1 | Status: COMPLETED